Skip to main content

Table 5 Clinical and laboratory findings in incomplete KD in the 2000–2004 group and the 2010–2014 group (n = 228)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

  2000–2004 (n = 74) 2010–2014 (n = 154) P
Age (month) 29.3 ± 24.8 26.9 ± 22.0 0.456
Sex (M/F) 44/30 98/56 0.562
Fever (day)
 Preadmission 5.5 ± 2.8 4.2 ± 1.5 < 0.001
 Total 7.9 ± 3.9 6.0 ± 1.6 < 0.001
Hospitalization (d) 8.6 ± 4.5 5.6 ± 1.7 < 0.001
Repeated IVIG, n (%) 6 (8.1) 7 (4.5) 0.358
CALs, n (%) 22 (29.7) 24 (15.6) 0.015
 Ectasia 19 (25.7) 23 (14.9) 0.067
 Aneurysm 3 (4.0) 1 (0.6) 0.102
WBC (/mm3) 15,500 ± 5000 14,800 ± 4900 0.291
 Neutrophil (%) 60.5 ± 17.1 61.6 ± 14.8 0.599
 Lymphocyte (%) 24.9 ± 13.7 27.7 ± 11.7 0.116
Hemoglobin (g/dL) 10.7 ± 0.8 11.4 ± 1.0 < 0.001
Platelet (/mm3) 324 ± 191 341 ± 108 0.010
Platelet, follow-up 550 ± 291 418 ± 146 < 0.001
CRP (mg/dL) 10.4 ± 6.8 8.0 ± 4.9 0.008
ESR (mm/h) 60 ± 23 70 ± 28 < 0.001
Total protein (g/dL) 6.4 ± 0.7 6.5 ± 0.6 0.703
Albumin (g/dL) 3.5 ± 0.4 3.9 ± 0.5 < 0.001
AST (IU/L) 43 ± 39 96 ± 297 0.030
ALT (IU/L) 65 ± 82 108 ± 174 0.021
ALT <40 IU, n (%) 42 (56.8) 81 (52.6) 0.888
ALT 40–100 IU, n (%) 18 (24.3) 32 (20.8) 0.616
ALT >100 IU, n (%) 14 (18.9) 41 (26.6) 0.241
  1. Values are mean ± SD or n (%). Abbreviations as in Table 1